This article is available to subscribers. Subscribe now. Already have an account? Sign in

Original ArticleFree PreviewArchive

Non-Endemic Burkitt's Lymphoma — A B-Cell Tumor Related to Germinal Centers

List of authors.
  • Risa B. Mann, M.D.,
  • Elaine S. Jaffe, M.D.,
  • Raul C. Braylan, M.D.,
  • Koji Nanba, M.D.,
  • Michael M. Frank, M.D.,
  • John L. Ziegler, M.D.,
  • and Costan W. Berard, M.D.

Abstract

To investigate the nature of non-endemic Burkitt's lymphoma, we examined neoplastic cells from eight American patients for receptors for sheep erythrocytes (E), complement (EAC), and Fc fragment of IgG (IgGEA), and for surface immunoglobulins (Slg) and hydrolytic enzymes. In addition, we reviewed 47 biopsies and 17 autopsies from American patients to ascertain patterns of involvement by tumor in lymph nodes, spleens and Peyer's patches. Neoplastic cells in all cases studied bore monoclonal surface immunoglobulins of the IgM class. Receptors for EAC and IgGEA were identified on a minority of the cells. Little or no hydrolytic enzyme activity was demonstrable. These results indicate that, like Burkitt's lymphoma in Africans, this histologically identical tumor in American patients consists of B lymphocytes. In 10 biopsies and two autopsies, germinal centers were selectively involved by tumor, suggesting that these neoplastic cells may be related to some B lymphocytes of normal germinal centers. (N Engl J Med 295:685–691, 1976)

Funding and Disclosures

We are indebted to Mrs. Eileen Sussman, Miss Sheila Sanders and Mr. Edward J. Soban for technical assistance, to Mr. Ralph Isenburg for photographic assistance and to Mrs. Pauline Juhasz for assistance (all of the Laboratory of Pathology of the National Cancer Institute).

Author Affiliations

From the Hematopathology Section, Laboratory of Pathology, and the Pediatric Oncology Branch, National Cancer Institute, and the Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, National Institutes of Health (address reprint requests to Dr. Mann at the Hematopathology Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20014).

Print Subscriber? Activate your online access.